Publications by authors named "Guido Camma"
Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review.
Eur Neuropsychopharmacol
November 2024
Article Synopsis
- Interest in the therapeutic potential of cannabinoids for mental health is increasing, particularly for conditions like anxiety, depression, and addiction, due to the role of the endocannabinoid system in these disorders.
- Research has mainly focused on the well-known cannabinoids CBD and Δ9-THC, but there are about 120 lesser-known cannabinoids with varying effects that haven't been thoroughly studied.
- A systematic review analyzed 22 preclinical studies and one clinical study on minor cannabinoids for various psychiatric conditions, finding that certain cannabinoids like Δ8-THCV, Δ9-THCV, CBDA-ME, and CBDV show promise for conditions ranging from addiction to anxiety and autism spectrum disorders, despite some inconsistencies in the results.
Background: White matter hyperintensities (WMH) are associated with cognitive dysfunction after ischemic stroke. Yet, uncertainty remains about affected domains, the role of other preexisting brain injury, and infarct types in the relation between WMH burden and poststroke cognition. We aimed to disentangle these factors in a large sample of patients with ischemic stroke from different cohorts.
View Article and Find Full Text PDF